• No results found

Bombyx Mori Chitosan Nanoparticles: Synthesis and Properties

N/A
N/A
Protected

Academic year: 2020

Share "Bombyx Mori Chitosan Nanoparticles: Synthesis and Properties"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Figure

Figure 1. IR-spectra: (a)-native; (b)-purified chitosan, Nsolubility-98.8%, Iб-8.48%, ash-1.58, k-36%
Figure 2. Nano-Chs Вм with stabilizer + UZD: Dimensions of nano-Chs-P: length—120 nm, width—7 nm
Table 1. Effect of nanopreparations on the number of cells in the central and peripheral immune organs in mice (M ± m, n = 6)
Table 2. Effect of chitosan and nanochitosan on leukocytes and red blood cells number of the mice peripheral blood
+3

References

Related documents

From looking at the spectrum with the high cut-o energy (orange line) it becomes also apparent that we have a dip in the spectrum at ≈ 110 eV. We will provide evidences that it

In the following, the event selection used in the three analyses will be presented (Section 2) before describing the SM background estimation techniques (Section 3).. The last

In this study, we designed a biocompatible phospholipid-coated drug-delivery system based on hollow calcium phosphate (HCP) nanoparticles for co-delivery of DOX and

In addition to showing resistance to TMP/SMX and CAZ, the latter patient CF6 isolate was resistant to ciprofloxacin (MIC of ⱖ 32 ␮ g/ml; Table S3), a fluoroquinolone antibiotic

Individuals with type 2 diabetes self-reported a higher level of exposure to heavy vehicle traffic than the general population, and this difference could partly explain the

Twenty-five percent of our respondents listed unilateral hearing loss as an indication for BAHA im- plantation, and only 17% routinely offered this treatment to children with

Under normally incident pump, our nanoantenna supports resonant responses at both the fundamental and harmonic wavelengths, enabling a high second-harmonic conversion efficiency of

Purpose: The aim of this study was to evaluate the cost-effectiveness of ribociclib compared to palbociclib, both in combination with letrozole, in the first-line treatment